Enhanced hippocampal neurogenesis mediated by PGC-1α-activated OXPHOS after neonatal low-dose Propofol exposure

Keyu Chen1,2, Dihan Lu1,2, Xiaoyu Yang1

  • 1Department of Anesthesiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Insights

Low-dose Propofol anesthesia may enhance spatial cognition in developing brains by boosting neurogenesis and mitochondrial function. This suggests potential benefits for pediatric use, contrary to previous concerns.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Anesthesiology

Background:

  • Pediatric anesthetic use raises concerns regarding neurodevelopmental effects.
  • Low-dose Propofol's impact on developing brains requires urgent investigation.

Purpose of the Study:

  • To investigate the neuronal effects of low-dose Propofol on the developing brain.
  • To clarify the cognitive and cellular impacts of neonatal Propofol exposure.

Main Methods:

  • Neonatal mice exposed to low-dose/high-dose Propofol underwent behavioral testing.
  • Neurogenesis was assessed in hippocampal and neural stem cells (NSCs).
  • Transcriptome and metabolism analyses (snRNA-seq, bulk RNA-seq) identified key pathways, with PGC-1α modulation confirmed using RNA interference and viral vectors.

Main Results:

  • Low-dose Propofol exposure enhanced spatial cognitive ability in mice.
  • Neurogenesis was significantly activated in both hippocampal and cultured NSCs.
  • Mitochondrial oxidative phosphorylation (OXPHOS) levels increased, with PGC-1α upregulation identified as a key mechanism.

Conclusions:

  • Low-dose Propofol alters mitochondrial function, enhancing hippocampal neurogenesis.
  • Findings suggest low-dose Propofol may be safe and potentially beneficial for pediatric use.
  • This study highlights a novel mechanism involving PGC-1α and OXPHOS in Propofol's neurodevelopmental effects.
Abstract

Related Concept Videos